Ophthalmic Viscoelastic Devices (OVD) Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

Ophthalmic Viscoelastic Devices (OVD) Market Overview

The market reached a value of approximately USD 2964.59 Million in 2025. The market is anticipated to witness consistent expansion, driven by a rising CAGR over the forecast period, supported by rising cataract surgery volumes, the increasing geriatric population, and surging demand for premium intraocular lenses. The shift toward viscoadaptive and combination OVD packaging is accelerating procedural efficiency. Integration with broader ophthalmic surgicaldevices ecosystems and innovations in semi-synthetic and viscoadaptive formulations are further strengthening growth. Additionally, the rising diabetes prevalence and growing minimally invasive glaucoma surgery (MIGS) volumes are pushing utilization. Increasing investments by leading players in dual-pack and prefilled syringe formats, alongside broader expansion across the ophthalmic devices landscape, are expected to sustain long-term market expansion.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Ophthalmic Viscoelastic Devices (OVD) Market Segmentation

Ophthalmic Viscoelastic Devices (OVD) Market Growth Analysis and Key Influencers

Ophthalmic Viscoelastic Devices (OVD) Market Dynamics

This section analyzes key factors influencing market growth, including rising cataract and glaucoma surgical volumes, technological substitution from low-OVD fluidics, evolving premium IOL adoption, and competitive product launches, while integrating interlinking keywords to highlight ecosystem-wide industry connections.

Ophthalmic Viscoelastic Devices (OVD) Market Drivers

Premium IOL Adoption and Cataract Surgery Growth Driving the Market Demand

The expanding adoption of premium presbyopia-correcting and extended depth of focus intraocular lenses is a major driver of OVD market growth, supported by rising cataract surgery volumes and growing patient demand for spectacle independence. For instance, in March 2026, Johnson & Johnson received FDA approval for the TECNIS PureSee EDOF intraocular lens, with the device's directions for use specifying that the HEALON family of OVDs is required for optimal performance during implantation. These integrated workflows enhance surgical precision and patient outcomes, thereby driving market growth during the forecast period, with strong synergies extending to the broader intraocular lens segment globally.

Ophthalmic Viscoelastic Devices (OVD) Market Restraints

Advancements in Low-OVD Surgical Technologies Limiting Conventional OVD Adoption

The introduction of low-OVD or OVD-free surgical techniques remains a significant restraint for ophthalmic viscoelastic devices, particularly in mature high-income markets. Modern phacoemulsification fluidics platforms stabilize the anterior chamber with balanced salt solution, reducing viscoelastic volume per case. Manufacturers are responding through the development of viscoadaptive single-syringe formulations, sorbitol-enhanced free-radical protection, and prefilled syringe formats, which are improving clinical value and supporting sustained adoption across the market during the forecast period.

Ophthalmic Viscoelastic Devices (OVD) Market Opportunities

Dual-Action and Sorbitol-Enhanced OVD Innovation Creating Opportunities

Continuous innovation in premium toric IOL platforms and dual-action OVD formulations is creating strong growth opportunities, supported by rising surgical safety expectations and growing premium-IOL adoption. For instance, in October 2025, Rayner Intraocular Lenses Limited received FDA approval for its RayOne EMV Toric intraocular lens following a successful pivotal Investigational Device Exemption (IDE) study, expanding the premium toric cataract surgical environment in which advanced viscoelastic devices are deployed for endothelial protection and anterior chamber maintenance during IOL implantation. These advancements enhance clinical safety and surgical efficiency, driving recurring demand and strengthening growth prospects across the cataract surgery devices landscape, reinforcing demand across the cataract surgery device segment.

Ophthalmic Viscoelastic Devices (OVD) Market Trends

Viscoadaptive Formulation Adoption and Premium Surgical Platform Expansion Shaping Market Evolution

The growing adoption of viscoadaptive OVD formulations alongside next-generation cataract surgical platforms is a key trend shaping the market, supported by rising complex cataract and premium IOL surgery volumes. For instance, in February 2026, Alcon confirmed during its Q4 2025 earnings call that UNITY VCS had been introduced across most major markets worldwide and that UNITY CS rollout would continue expanding global availability throughout 2026, broadening the surgical platform footprint in which premium viscoelastic devices are deployed. The trend is set to strengthen the ophthalmic surgery market during the forecast period, supported by parallel demand growth across the broader eye care landscape.

Ophthalmic Viscoelastic Devices (OVD) Market Share

Dispersive OVD Segment Likely to Dominate the Market Share by Product

The dispersive OVD segment dominated the market with approximately 37% revenue share in the historical period, driven by its superior corneal endothelial protection during cataract surgery. Dispersive OVDs create a stable viscoelastic environment that helps maintain intraocular pressure and protects delicate tissues. Continuous innovation in sodium hyaluronate and chondroitin sulfate formulations supports clinical reliability. Furthermore, growing synergy with phacoemulsification workflows further reinforces clinical adoption and operational efficiency.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Ophthalmic Viscoelastic Devices (OVD) Market Analysis by Region

North America is likely to dominate the market as it accounted for about 37% market share in the historical period, supported by a significant population with cataract and glaucoma disorders, robust healthcare infrastructure, and increasing R&D investments by key players. The United States market leads regional growth due to its large geriatric population and extensive healthcare coverage. Additionally, growing integration with medicare reimbursement frameworks, rising premium IOL adoption and growing procedural integration with the ophthalmic diagnostic devices segment further support steady market growth during the forecast period.

Leading Players in the Ophthalmic Viscoelastic Devices (OVD) Market

Key Questions Answered in the Ophthalmic Viscoelastic Devices (OVD) Market Report

• What was the ophthalmic viscoelastic devices (OVD) market value in 2025?
• What is the OVD market forecast outlook for 2026-2035?
• What major factors aid the demand for the OVD market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major OVD market trends?
• Which type is expected to dominate the market segment?
• Which application is expected to dominate the market segment?
• Which end users is expected to dominate the market segment?
• Who are the key players in the OVD market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?